+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Studies on the thyrotropic activity of human chorionic gonadotropin and its derivatives

Folia Endocrinologica Japonica 61(11): 1228-1238
Studies on the thyrotropic activity of human chorionic gonadotropin and its derivatives
The placenta may be involved in the regulation of the maternal thyroid function during pregnancy. As human chorionic gonadotropin (hCG) is a primary protein from the placenta, we examined the thyrotropic activity of hCG and its derivatives using tissue culture and monolayer cell culture of human thyroid glands. The TSH receptor preparation was made from thyroid tissues, and its binding affinity with hCG and Asialo hCG (As-hCG) was examined. hCG did not bind to TSH receptor, but As-hCG did. In the experiment with tissue culture, TSH, hCG, hCG.alpha., .beta. subunit and As-hCG were added to the culture medium. Secretions of L-thyroxine (T4) and L-triiodothyronine (T3) in the culture medium were measured at regular time intervals. While TSH showed increases of T4 and T3 secretion, other hCG derivatives did not show any differences from the control values. When TSH and hCG were added together, the secretion of thyroid hormone was the same as that obtained by TSH single administration. On the other hand, the secretion of T4 and T3 was inhibited with co-administration of TSH and As-hCG. Only TSH and none of the other hCG derivatives showed the dose-dependent stimulation of T4 and T3 secretion. A similar experiment was carried out in a monolayer cell culture obtained by trypsin treatment of human thyroid tissue. The secretions of cyclic AMP (c-AMP), T4 and T3 were measured. As in the previous tissue experiment, the thyrotropic activity of TSH was not modified by hCG, but the secretions of T4, T3 and especially c-AMP were inhibited by coadministration of As-hCG and TSH. These findings suggest that hCG and its subunits do not show thyrotropic activity in human thyroid glands, but As-hCG acts as an antagonist of TSH.

(PDF 0-2 workdays service: $29.90)

Accession: 006522498

Related references

Low in vitro thyrotropic activity of a human chorionic gonadotropin molecule in the first trimester during pregnancy. Gynecologic and Obstetric Investigation 46(2): 75-79, 1998

Does human chorionic gonadotropin have human thyrotropic activity in vivo?. Gynecological Endocrinology 11(3): 195-201, 1997

Thyrotropic activity of acidic isoelectric variants of human chorionic gonadotropin from trophoblastic tumors. Endocrinology 118(4): 1558-1566, 1986

On the thyrotropic activity of human chorionic gonadotropin: its role as the thyroid stimulator of trophoblastic origin. Progress in Clinical and Biological Research 116: 207-223, 1983

Studies on the immunological and receptor binding activity of human chorionic gonadotropin and its derivatives. Federation Proceedings 35(7): 1836, 1976

Maternal thyroid function in multiple pregnancy: the variable thyrotropic activity of human chorionic gonadotropin. Hormone and Metabolic Research 30(11): 689-693, 1999

Sialic acid residues of the alpha subunit are required for thyrotropic activity of human chorionic gonadotropin. Biochemical & Biophysical Research Communications 109(1): 146-151, 1982

Human chorionic gonadotropin (hCG) and thyroid function in early human pregnancy: circadian variation and evidence for intrinsic thyrotropic activity of hCG. Journal of Clinical Endocrinology and Metabolism 66(4): 853-856, 1988

Biochemical study on the thyrotropic activity in urinary immunoreactive-human chorionic gonadotropin of patients with trophoblastic disease. Nihon Sanka Fujinka Gakkai Zasshi 39(4): 539-546, 1987

Biochemical study on the thyrotropic activity in urinary immunoreactive human chorionic gonadotropin of the patients with trophoblastic disease. Acta Obstetrica et Gynaecologica Japonica (Japanese Edition) 39(4): 539-546, 1987